The weekly litigation news digest is live. Subscribe now

Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation - EP3045471

The patent EP3045471 was granted to Ferring on Mar 29, 2017. The application was originally filed on Apr 16, 2009 under application number EP16158141A. The patent is currently recorded with a legal status of "Revoked".

EP3045471

FERRING
Application Number
EP16158141A
Filing Date
Apr 16, 2009
Status
Revoked
Jan 7, 2022
Publication Date
Mar 29, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MERCK SERONODec 22, 2017WEISS -

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONUS5994128
OPPOSITIONWO03035686
OPPOSITIONWO03048348
OPPOSITIONWO2005080585
OPPOSITIONWO9700326
SEARCHWO03035686
SEARCHWO2012016576

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents